OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
0809$0.0658

Global Bio-chem Technology Group Co Ltd

Agricultural ChemicalsVerified

Global Bio-chem Technology Group Co Ltd operates with a negative total equity of HKD -518.5 million and a debt-to-equity ratio of -3.46, indicating a highly leveraged capital structure. The company's current ratio of 0.49 suggests liquidity constraints, as current assets are significantly lower than current liabilities. The market capitalization of HKD 973.7 million is modest relative to its revenue of HKD 2.28 billion, with a price-to-earnings ratio of 6.23 and an EV/EBITDA of 5.96. Profitability metrics show a return on assets of 3.38%, but a negative return on equity of -30.14%, reflecting the company's negative equity position. The gross profit of HKD 196.4 million and operating income of HKD 464.5 million are modest relative to revenue, with gross margin at 8.62% and operating margin at 20.38%. These figures are below the industry median for Agricultural Chemicals, where gross margins typically exceed 15% and operating margins exceed 25%. The company's revenue is distributed across four segments: Amino Acids, Upstream Products, Corn Sweeteners, and Polyol Chemicals. No segment breakdown is provided in the input data, but the Upstream Products segment is likely the largest contributor due to the company's corn-based operations. Geographically, the company is primarily exposed to the Asia-Pacific region, with no disclosed international revenue concentration. Outlook for the current fiscal year shows a revenue of HKD 2.28 billion, with no disclosed growth rate. The company's net income of HKD 156.3 million is a decline from prior periods, and the outlook for the next fiscal year is not provided. The company's liquidity risk is rated as medium, with a negative net cash position after subtracting total debt. The company's risk assessment indicates a low dilution risk, with no near-term pressure for equity issuance. However, the negative equity position and high leverage increase the risk of financial distress. The company has not disclosed any recent events, such as regulatory changes or major business developments, that would significantly impact its operations.

30-day price · 0809+0.01 (+10.3%)
Low$0.06High$0.07Close$0.06As of22 May, 00:00 UTC
Profile
CompanyGlobal Bio-chem Technology Group Co Ltd
Ticker0809.HK
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Global Bio-chem Technology Group Co Ltd is an investment holding company engaged in the manufacturing and sales of biochemical products, including lysine, threonine, corn starch, corn sweeteners, and polyol chemicals.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry, with a classification confidence of 0.92.

Global Bio-chem Technology Group Co Ltd operates with a negative total equity of HKD -518.5 million and a debt-to-equity ratio of -3.46, indicating a highly leveraged capital structure. The company's current ratio of 0.49 suggests liquidity constraints, as current assets are significantly lower than current liabilities. The market capitalization of HKD 973.7 million is modest relative to its revenue of HKD 2.28 billion, with a price-to-earnings ratio of 6.23 and an EV/EBITDA of 5.96. Profitability metrics show a return on assets of 3.38%, but a negative return on equity of -30.14%, reflecting the company's negative equity position. The gross profit of HKD 196.4 million and operating income of HKD 464.5 million are modest relative to revenue, with gross margin at 8.62% and operating margin at 20.38%. These figures are below the industry median for Agricultural Chemicals, where gross margins typically exceed 15% and operating margins exceed 25%. The company's revenue is distributed across four segments: Amino Acids, Upstream Products, Corn Sweeteners, and Polyol Chemicals. No segment breakdown is provided in the input data, but the Upstream Products segment is likely the largest contributor due to the company's corn-based operations. Geographically, the company is primarily exposed to the Asia-Pacific region, with no disclosed international revenue concentration. Outlook for the current fiscal year shows a revenue of HKD 2.28 billion, with no disclosed growth rate. The company's net income of HKD 156.3 million is a decline from prior periods, and the outlook for the next fiscal year is not provided. The company's liquidity risk is rated as medium, with a negative net cash position after subtracting total debt. The company's risk assessment indicates a low dilution risk, with no near-term pressure for equity issuance. However, the negative equity position and high leverage increase the risk of financial distress. The company has not disclosed any recent events, such as regulatory changes or major business developments, that would significantly impact its operations.
Key takeaways
  • The company is highly leveraged with a negative equity position and a debt-to-equity ratio of -3.46.
  • Profitability is constrained by a negative return on equity of -30.14% and a low return on assets of 3.38%.
  • Liquidity is a concern, with a current ratio of 0.49 and a negative net cash position.
  • The company's revenue is concentrated in corn-based biochemical products, with no disclosed international diversification.
  • No near-term dilution risk is identified, but the company's financial structure increases the risk of financial distress.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyHKD
Revenue$2.28B
Gross profit$196.4M
Operating income$464.5M
Net income$156.3M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$4.62B
Total liabilities$5.14B
Total equity-$518.5M
Cash & equivalents
Long-term debt$1.79B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$0.06
Market cap$973.7M
Enterprise value$2.77B
P/E6.2
Reported non-GAAP P/E
EV/Revenue1.2
EV/Op income6.0
EV/OCF
P/B
P/Tangible book
Tangible book-$518.5M
Net cash-$1.79B
Current ratio0.5
Debt/Equity-3.5
ROA3.4%
ROE-30.1%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric0809Activity
Op margin20.4%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin6.9%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin8.6%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue6.2% medp25 5.4% · p75 10.2%
Debt / equity-346.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS0.40 HKD
Last actual revenue14,438,887,000 HKD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 13:50 UTC#b3707ac0
Market quoteclose HKD 0.06 · shares 16.79B diluted
no public URL
2026-05-10 13:50 UTC#c9e2f7d4
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 13:52 UTCJob: 11a4905b